Rekvina Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	-	0.25	0.1	0.1	0	0.02
Cash & Short-Term Investments	0.02	0.25	0.1	0.1	0	0.02
Cash Growth	-98.19%	164.21%	-3.06%	2563.04%	-82.48%	-80.91%
Receivables	-	-	-	-	-	0.07
Other Current Assets	-	0.07	-	-	-	-
Total Current Assets	-	0.33	0.1	0.1	0	0.09
Property, Plant & Equipment	-	-	-	1.46	1.46	-
Long-Term Investments	-	-	-	0.46	0.46	0.49
Other Long-Term Assets	-	-	-	-	-	1.85
Total Assets	-	0.33	0.1	2.02	1.92	2.43
Accounts Payable	-	1.07	1.14	1.06	1.76	1.5
Accrued Expenses	-	0.11	0.01	0.02	0.03	-
Short-Term Debt	-	2.47	0.4	0.81	-	-
Other Current Liabilities	-	-	0.5	0	-	-
Total Current Liabilities	-	3.65	2.05	1.89	1.78	1.5
Total Liabilities	-	3.65	2.05	1.89	1.78	1.5
Common Stock	-	30.14	30.14	30.14	30.14	30.14
Retained Earnings	-	-33.46	-32.09	-30.01	-30	-
Comprehensive Income & Other	-	-	-	-	-	-29.21
Shareholders' Equity	-7.53	-3.32	-1.95	0.13	0.14	0.93
Total Liabilities & Equity	-	0.33	0.1	2.02	1.92	2.43
Total Debt	8.12	2.47	0.4	0.81	-	-
Net Cash (Debt)	-8.11	-2.22	-0.3	-0.72	0	0.02
Net Cash Growth	-	-	-	-	-82.48%	-80.91%
Net Cash Per Share	-1.32	-0.37	-0.05	-0.12	0.00	-
Filing Date Shares Outstanding	5.9	6.03	6.03	6.03	6.07	-
Total Common Shares Outstanding	5.9	6.03	6.03	6.03	6.07	-
Working Capital	-	-3.32	-1.95	-1.79	-1.78	-1.41
Book Value Per Share	-1.29	-0.55	-0.32	0.02	0.02	-
Tangible Book Value	-7.53	-3.32	-1.95	0.13	0.14	0.93
Tangible Book Value Per Share	-1.29	-0.55	-0.32	0.02	0.02	-
Land	-	-	-	0.17	0.17	-
Buildings	-	-	-	2.03	2.02	-
Machinery	-	-	-	2.9	2.9	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.